Characterization of the primer sets used for the analysis of AI
Marker . | Chrom. Region . | Description . |
---|---|---|
D6S474 | 6q21-22 | BFD4 (Body fluid distribution QTL 4) |
D6S1631 | 6q16 | Transforming growth factor-β–activating kinase |
D7S522 | 7q31.1 | Caveolin 1 |
D8S87 | 8p12 | Neuregulin 1 |
D8S137 | 8p21.1 | Dematin |
D8S286 | 8q21.3 | HNF-4γ (Hepatocyte nuclear factor-4γ) |
D8S360 | 8p21 | n.a |
D9S171 | 9p21-22 | CDKN2/p16 |
D9S1748 | 9p21 | CDKN2/p16 |
D10S1765 | 10q23.3 | PTEN (Phosphatase and tensin homologue) |
D10S541 | 10q23 | PTEN |
D11S898 | 11q22 | n.a. |
D11S1313 | 11q12-13 | CORS2 (Cerebello-oculo-renal syndrome 2) |
D17S1855 | 17q21 | BRCA1 (Breast cancer type 1) |
Marker . | Chrom. Region . | Description . |
---|---|---|
D6S474 | 6q21-22 | BFD4 (Body fluid distribution QTL 4) |
D6S1631 | 6q16 | Transforming growth factor-β–activating kinase |
D7S522 | 7q31.1 | Caveolin 1 |
D8S87 | 8p12 | Neuregulin 1 |
D8S137 | 8p21.1 | Dematin |
D8S286 | 8q21.3 | HNF-4γ (Hepatocyte nuclear factor-4γ) |
D8S360 | 8p21 | n.a |
D9S171 | 9p21-22 | CDKN2/p16 |
D9S1748 | 9p21 | CDKN2/p16 |
D10S1765 | 10q23.3 | PTEN (Phosphatase and tensin homologue) |
D10S541 | 10q23 | PTEN |
D11S898 | 11q22 | n.a. |
D11S1313 | 11q12-13 | CORS2 (Cerebello-oculo-renal syndrome 2) |
D17S1855 | 17q21 | BRCA1 (Breast cancer type 1) |
Abbreviations: Chrom. region, chromosome region; n.a., not analyzed.